BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

220 related articles for article (PubMed ID: 20348143)

  • 1. The likelihood of decreasing strokes in atrial fibrillation patients by strict application of guidelines.
    Pisters R; van Oostenbrugge RJ; Knottnerus IL; de Vos CB; Boreas A; Lodder J; Prins MH; Crijns HJ; Tieleman RG
    Europace; 2010 Jun; 12(6):779-84. PubMed ID: 20348143
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Anticoagulant and antiplatelet therapy for stroke prevention in atrial fibrillation patients in the clinical practice of a single district hospital in Poland.
    Bednarski J; Cieszewska E; Strzelecki A; Filipiak KJ
    Kardiol Pol; 2013; 71(12):1260-5. PubMed ID: 23990227
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Impact of atrial fibrillation and inadequate antithrombotic management on mortality in acute neurovascular syndrome.
    Saarinen JT; Rusanen H; Sillanpää N; Huhtala H; Numminen H; Elovaara I
    J Stroke Cerebrovasc Dis; 2014 Oct; 23(9):2256-64. PubMed ID: 25156784
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Oral anticoagulation use by patients with atrial fibrillation in Germany. Adherence to guidelines, causes of anticoagulation under-use and its clinical outcomes, based on claims-data of 183,448 patients.
    Wilke T; Groth A; Mueller S; Pfannkuche M; Verheyen F; Linder R; Maywald U; Kohlmann T; Feng YS; Breithardt G; Bauersachs R
    Thromb Haemost; 2012 Jun; 107(6):1053-65. PubMed ID: 22398417
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Initiation of oral anticoagulation after acute ischaemic stroke or transient ischaemic attack: timing and complications of overlapping heparin or conventional treatment.
    Audebert HJ; Schenk B; Tietz V; Schenkel J; Heuschmann PU
    Cerebrovasc Dis; 2008; 26(2):171-7. PubMed ID: 18628615
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Potentially preventable strokes in high-risk patients with atrial fibrillation who are not adequately anticoagulated.
    Gladstone DJ; Bui E; Fang J; Laupacis A; Lindsay MP; Tu JV; Silver FL; Kapral MK
    Stroke; 2009 Jan; 40(1):235-40. PubMed ID: 18757287
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Anticoagulation remains underused in prevention of stroke associated with atrial fibrillation: insights from two consecutive national surveys.
    Schwammenthal Y; Bornstein NM; Goldbourt U; Koton S; Schwartz R; Koren-Morag N; Grossman E; Tanne D
    Int J Cardiol; 2011 Nov; 152(3):356-61. PubMed ID: 20851475
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Is atrial fibrillation always a culprit of stroke in patients with atrial fibrillation plus stroke?
    Kim SJ; Ryoo S; Kwon S; Park YK; Kim JP; Lee GY; Bang OY
    Cerebrovasc Dis; 2013; 36(5-6):373-82. PubMed ID: 24217395
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Guideline-adherent antithrombotic treatment is associated with improved outcomes compared with undertreatment in high-risk patients with atrial fibrillation. The Euro Heart Survey on Atrial Fibrillation.
    Nieuwlaat R; Olsson SB; Lip GY; Camm AJ; Breithardt G; Capucci A; Meeder JG; Prins MH; Lévy S; Crijns HJ;
    Am Heart J; 2007 Jun; 153(6):1006-12. PubMed ID: 17540203
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Use and underuse of oral anticoagulation for stroke prevention in atrial fibrillation: old and new paradigms.
    Pisters R; de Vos CB; Nieuwlaat R; Crijns HJ
    Semin Thromb Hemost; 2009 Sep; 35(6):554-9. PubMed ID: 19787559
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prognosis in patients with atrial fibrillation and CHA2DS2-VASc Score = 0 in a community-based cohort study.
    Taillandier S; Olesen JB; Clémenty N; Lagrenade I; Babuty D; Lip GY; Fauchier L
    J Cardiovasc Electrophysiol; 2012 Jul; 23(7):708-13. PubMed ID: 22268375
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antithrombotic treatment in real-life atrial fibrillation patients: a report from the Euro Heart Survey on Atrial Fibrillation.
    Nieuwlaat R; Capucci A; Lip GY; Olsson SB; Prins MH; Nieman FH; López-Sendón J; Vardas PE; Aliot E; Santini M; Crijns HJ;
    Eur Heart J; 2006 Dec; 27(24):3018-26. PubMed ID: 16731536
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Population-based evaluation of the management of antithrombotic therapy for atrial fibrillation.
    Anderson DR; Gardner MJ; Putnam W; Jassal D; Brownell B; Flowerdew G; Nagpal S; Thompson K; Cox JL
    Can J Cardiol; 2005 Mar; 21(3):257-66. PubMed ID: 15776115
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prestroke anticoagulation and paroxysmal type are correlated with favorable outcome in ischemic stroke patients with atrial fibrillation.
    Hoshino H; Itoh Y; Kimura H; Miyaki K; Suzuki N
    J Stroke Cerebrovasc Dis; 2012 Jan; 21(1):11-7. PubMed ID: 20833081
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Potential net clinical benefit of population-wide implementation of apixaban and dabigatran among European patients with atrial fibrillation. A modelling analysis from the Euro Heart Survey.
    Pisters R; Nieuwlaat R; Lane DA; Crijns HJ; Lip GY
    Thromb Haemost; 2013 Feb; 109(2):328-36. PubMed ID: 23179181
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Relation of effective anticoagulation in patients with atrial fibrillation to stroke severity and survival (from the National Acute Stroke Israeli Survey [NASIS]).
    Schwammenthal Y; Bornstein N; Schwammenthal E; Schwartz R; Goldbourt U; Tsabari R; Koton S; Grossman E; Tanne D
    Am J Cardiol; 2010 Feb; 105(3):411-6. PubMed ID: 20102959
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Gender differences in stroke risk of atrial fibrillation patients on oral anticoagulant treatment.
    Poli D; Antonucci E; Grifoni E; Abbate R; Gensini GF; Prisco D
    Thromb Haemost; 2009 May; 101(5):938-42. PubMed ID: 19404548
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Newly detected atrial fibrillation and compliance with antithrombotic guidelines.
    Glazer NL; Dublin S; Smith NL; French B; Jackson LA; Hrachovec JB; Siscovick DS; Psaty BM; Heckbert SR
    Arch Intern Med; 2007 Feb; 167(3):246-52. PubMed ID: 17296879
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Benefits and risks of oral anticoagulation for stroke prevention in nonvalvular atrial fibrillation.
    Garcia DA
    Thromb Res; 2012 Jan; 129(1):9-16. PubMed ID: 22018997
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Alcohol-related hospitalization is associated with increased risk of ischaemic stroke among low-risk patients with atrial fibrillation.
    Al-Khalili F; Benson L; Friberg L
    Europace; 2018 Jan; 20(1):19-24. PubMed ID: 28339885
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.